Moschos SA - Search Results

1

A new threat from an old enemy: Re‑emergence of coronavirus (Review).

Docea AO, Tsatsakis A, Albulescu D, Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou M, Drakoulis N, Dumanov JM, Tutelyan VA, Onischenko GG, Aschner M, Spandidos DA, Calina D. Docea AO, et al. Among authors: moschos sa. Int J Mol Med. 2020 Jun;45(6):1631-1643. doi: 10.3892/ijmm.2020.4555. Epub 2020 Mar 27. Int J Mol Med. 2020. PMID: 32236624 Free PMC article. Review.

2

Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review).

Nitulescu GM, Paunescu H, Moschos SA, Petrakis D, Nitulescu G, Ion GND, Spandidos DA, Nikolouzakis TK, Drakoulis N, Tsatsakis A. Nitulescu GM, et al. Among authors: moschos sa. Int J Mol Med. 2020 Aug;46(2):467-488. doi: 10.3892/ijmm.2020.4608. Epub 2020 May 18. Int J Mol Med. 2020. PMID: 32468014 Free PMC article. Review.

3

Oligonucleotide Therapies for the Lung: Ready to Return to the Clinic?

Kumar M, Moschos SA. Kumar M, et al. Among authors: moschos sa. Mol Ther. 2017 Dec 6;25(12):2604-2606. doi: 10.1016/j.ymthe.2017.11.002. Epub 2017 Nov 23. Mol Ther. 2017. PMID: 29174842 Free PMC article. No abstract available.

4

Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense.

Moschos SA, Frick M, Taylor B, Turnpenny P, Graves H, Spink KG, Brady K, Lamb D, Collins D, Rockel TD, Weber M, Lazari O, Perez-Tosar L, Fancy SA, Lapthorn C, Green MX, Evans S, Selby M, Jones G, Jones L, Kearney S, Mechiche H, Gikunju D, Subramanian R, Uhlmann E, Jurk M, Vollmer J, Ciaramella G, Yeadon M. Moschos SA, et al. Mol Ther. 2011 Dec;19(12):2163-8. doi: 10.1038/mt.2011.206. Epub 2011 Oct 4. Mol Ther. 2011. PMID: 21971426 Free PMC article.

5

Measuring the Action of Oligonucleotide Therapeutics in the Lung at the Cell Type-Specific Level by Tissue Disruption and Cell Sorting (TDCS).

Graves H, Evans S, Fauler M, Frick M, Moschos SA. Graves H, et al. Among authors: moschos sa. Methods Mol Biol. 2019;2036:187-203. doi: 10.1007/978-1-4939-9670-4_11. Methods Mol Biol. 2019. PMID: 31410798

6

Clinical potential of oligonucleotide-based therapeutics in the respiratory system.

Moschos SA, Usher L, Lindsay MA. Moschos SA, et al. Pharmacol Ther. 2017 Jan;169:83-103. doi: 10.1016/j.pharmthera.2016.10.009. Epub 2016 Oct 19. Pharmacol Ther. 2017. PMID: 27771436 Free article. Review.

7

Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAs.

Theotokis PI, Usher L, Kortschak CK, Schwalbe E, Moschos SA. Theotokis PI, et al. Among authors: moschos sa. Mol Ther Nucleic Acids. 2017 Dec 15;9:22-33. doi: 10.1016/j.omtn.2017.08.010. Epub 2017 Aug 24. Mol Ther Nucleic Acids. 2017. PMID: 29246301 Free PMC article.

8

Predicting oligonucleotide therapeutic efficacy at the population level.

Theotokis PI, Usher L, Kortschak CK, Schwalbe E, Moschos SA. Theotokis PI, et al. Among authors: moschos sa. Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:182. Hell J Nucl Med. 2019. PMID: 31802060 Free article.

9

Measuring the action of CPP-siRNA conjugates in the lung.

Moschos SA, Spink KG, Lindsay MA. Moschos SA, et al. Methods Mol Biol. 2011;683:417-29. doi: 10.1007/978-1-60761-919-2_30. Methods Mol Biol. 2011. PMID: 21053147

10

Maternally imprinted microRNAs are differentially expressed during mouse and human lung development.

Williams AE, Moschos SA, Perry MM, Barnes PJ, Lindsay MA. Williams AE, et al. Among authors: moschos sa. Dev Dyn. 2007 Feb;236(2):572-80. doi: 10.1002/dvdy.21047. Dev Dyn. 2007. PMID: 17191223 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page